Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%-49%: A network meta-analysis.
Nobuhiko FukudaNobuyuki HoritaHo NamkoongAyami KanekoKohei SomekawaYoichi TagamiKeisuke WatanabeYu HaraNobuaki KobayashTakeshi KanekoPublished in: Thoracic cancer (2021)
The combination therapies, which were the platinum regimen + Pemb and the platinum regimen + Niv + Ipi, rather than ICI monotherapy were effective first-line agents for treating squamous NSCLC with low PD-L1 levels.